MedTrace Logo

Efficacy of Neuro+ Attention Training

NCT02642055 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-12-21

No results posted yet for this study

Summary

This study evaluates the efficacy of the Neuro+ Attention Training System (Neuro+) in improving attention skills in children. Half of participants will receive the Neuro+ intervention for 10 weeks, while the other half will continue treatment as usual (TAU) for the same period. We expect those receiving the Neuro+ intervention to see significant improvements in ADHD symptoms relative to the TAU controls.

Conditions

  • ADHD

Interventions

BEHAVIORAL

Neuro+ Attention Training

Attention training program with Neuro+ software

OTHER

Treatment as Usual

Continuation of current ADHD treatment

Sponsors & Collaborators

  • Neuro+

    lead INDUSTRY

Principal Investigators

  • Sandeep Vaishnavi, MD, PhD · Carolina Partners in Mental HealthCare, PLLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02642055 on ClinicalTrials.gov